Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The impact of anti-angiogenic agents on cancer therapy.

Literature DB >> 13680378

The impact of anti-angiogenic agents on cancer therapy.

Dieter Marmé¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 13680378 DOI： 10.1007/s00432-003-0488-9

Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN： 0171-5216 Impact factor: 4.553

× No keyword cloud information.

59 in total

1. Circulating endothelial precursors: mystery, reality, and promise.

Authors: S Rafii
Journal: J Clin Invest Date: 2000-01 Impact factor: 14.808

Review 2. Mechanisms and functions of Eph and ephrin signalling.

Authors: Klas Kullander; Rüdiger Klein
Journal: Nat Rev Mol Cell Biol Date: 2002-07 Impact factor: 94.444

Review 3. Role of integrins in cell invasion and migration.

Authors: John D Hood; David A Cheresh
Journal: Nat Rev Cancer Date: 2002-02 Impact factor: 60.716

Review 4. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors.

Authors: U Eriksson; K Alitalo
Journal: Curr Top Microbiol Immunol Date: 1999 Impact factor: 4.291

5. Active interaction of human A375 melanoma cells with the lymphatics in vivo.

Authors: M Papoutsi; G Siemeister; K Weindel; S I Tomarev; H Kurz; C Schächtele; G Martiny-Baron; B Christ; D Marmé; J Wilting
Journal: Histochem Cell Biol Date: 2000-11 Impact factor: 4.304

6. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.

Authors: R M Shaheen; W W Tseng; D W Davis; W Liu; N Reinmuth; R Vellagas; A A Wieczorek; Y Ogura; D J McConkey; K E Drazan; C D Bucana; G McMahon; L M Ellis
Journal: Cancer Res Date: 2001-02-15 Impact factor: 12.701

7. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

Authors: T Mäkinen; T Veikkola; S Mustjoki; T Karpanen; B Catimel; E C Nice; L Wise; A Mercer; H Kowalski; D Kerjaschki; S A Stacker; M G Achen; K Alitalo
Journal: EMBO J Date: 2001-09-03 Impact factor: 11.598

8. VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors: Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal: Proc Natl Acad Sci U S A Date: 2002-08-12 Impact factor: 11.205

9. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

Authors: M Friedlander; C L Theesfeld; M Sugita; M Fruttiger; M A Thomas; S Chang; D A Cheresh
Journal: Proc Natl Acad Sci U S A Date: 1996-09-03 Impact factor: 11.205

10. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors: H U Wang; Z F Chen; D J Anderson
Journal: Cell Date: 1998-05-29 Impact factor: 41.582

5 in total

The impact of anti-angiogenic agents on cancer therapy.

1. Circulating endothelial precursors: mystery, reality, and promise.

Review 2. Mechanisms and functions of Eph and ephrin signalling.

Review 3. Role of integrins in cell invasion and migration.

Review 4. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors.

5. Active interaction of human A375 melanoma cells with the lymphatics in vivo.

6. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.

7. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

8. VEGF-Trap: a VEGF blocker with potent antitumor effects.

9. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

10. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

1. Protein kinase inhibitors: novel tools in cancer therapy.

2. Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

3. Angiogenesis and chronic kidney disease.

Review 4. Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.

5. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.